DK137706B - Fremgangsmåde til fremstilling af tørre farmaceutiske produkter, som kan indgives oralt, og som har en virkning, der strækker sig over en vis tidsperiode. - Google Patents

Fremgangsmåde til fremstilling af tørre farmaceutiske produkter, som kan indgives oralt, og som har en virkning, der strækker sig over en vis tidsperiode.

Info

Publication number
DK137706B
DK137706B DK250973AA DK250973A DK137706B DK 137706 B DK137706 B DK 137706B DK 250973A A DK250973A A DK 250973AA DK 250973 A DK250973 A DK 250973A DK 137706 B DK137706 B DK 137706B
Authority
DK
Denmark
Prior art keywords
preparation
certain period
time
administered orally
extending over
Prior art date
Application number
DK250973AA
Other languages
Danish (da)
English (en)
Other versions
DK137706C (fr
Inventor
Claude Mony
Genevieve Costes
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of DK137706B publication Critical patent/DK137706B/da
Application granted granted Critical
Publication of DK137706C publication Critical patent/DK137706C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
DK250973AA 1972-05-10 1973-05-08 Fremgangsmåde til fremstilling af tørre farmaceutiske produkter, som kan indgives oralt, og som har en virkning, der strækker sig over en vis tidsperiode. DK137706B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7216616A FR2183546B1 (fr) 1972-05-10 1972-05-10

Publications (2)

Publication Number Publication Date
DK137706B true DK137706B (da) 1978-04-24
DK137706C DK137706C (fr) 1982-11-15

Family

ID=9098254

Family Applications (1)

Application Number Title Priority Date Filing Date
DK250973AA DK137706B (da) 1972-05-10 1973-05-08 Fremgangsmåde til fremstilling af tørre farmaceutiske produkter, som kan indgives oralt, og som har en virkning, der strækker sig over en vis tidsperiode.

Country Status (17)

Country Link
US (1) US3950508A (fr)
JP (1) JPS5526124B2 (fr)
AR (1) AR203268A1 (fr)
BE (1) BE799331A (fr)
CA (1) CA1041906A (fr)
DD (1) DD104027A5 (fr)
DE (1) DE2323686A1 (fr)
DK (1) DK137706B (fr)
FI (1) FI56623C (fr)
FR (1) FR2183546B1 (fr)
GB (1) GB1421964A (fr)
HU (1) HU168307B (fr)
IL (1) IL42232A (fr)
IN (1) IN139518B (fr)
NL (1) NL158388B (fr)
OA (1) OA04380A (fr)
ZA (1) ZA733188B (fr)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3923939A (en) * 1974-06-07 1975-12-02 Alza Corp Process for improving release kinetics of a monolithic drug delivery device
GB1576376A (en) * 1977-03-30 1980-10-08 Benzon As Alfred Multiple-unit drug dose
US4264573A (en) * 1979-05-21 1981-04-28 Rowell Laboratories, Inc. Pharmaceutical formulation for slow release via controlled surface erosion
US4226849A (en) * 1979-06-14 1980-10-07 Forest Laboratories Inc. Sustained release therapeutic compositions
US4547358A (en) * 1980-05-06 1985-10-15 Mead Johnson & Company Sustained release tablet containing at least 95 percent theophylline
US4465660A (en) * 1981-04-01 1984-08-14 Mead Johnson & Company Sustained release tablet containing at least 95 percent theophylline
US4985017A (en) * 1981-07-13 1991-01-15 Alza Corporation Parenteral therapeutical system comprising drug cell
EP0094116A3 (fr) * 1982-05-06 1984-08-01 The Procter & Gamble Company Granulés thérapeutiques
US4415547A (en) * 1982-06-14 1983-11-15 Sterling Drug Inc. Sustained-release pharmaceutical tablet and process for preparation thereof
HU187215B (en) * 1983-01-26 1985-11-28 Egyt Gyogyszervegyeszeti Gyar Method for producing pharmaceutical product of high actor content and prolonged effect
DE3435325A1 (de) * 1983-04-09 1986-04-17 Nikken Chemicals Co., Ltd., Tokio/Tokyo Langzeitwirkende theophyllin-tablette und verfahren zu deren herstellung
WO1984004674A1 (fr) * 1983-05-31 1984-12-06 Jang Choong Gook Compositions seches a compression directe pour formes de dosage a liberation controlee
JPS60104804A (ja) * 1983-11-09 1985-06-10 Nippon Ferrite Ltd エア抜き装置
JPS60104805A (ja) * 1983-11-09 1985-06-10 Nippon Ferrite Ltd エア抜き装置
US4590062A (en) * 1984-04-16 1986-05-20 Tech Trade Corp. Dry direct compression compositions for controlled release dosage forms
US4772475A (en) * 1985-03-08 1988-09-20 Yamanouchi Pharmaceutical Co., Ltd. Controlled-release multiple units pharmaceutical formulation
GB8521350D0 (en) * 1985-08-28 1985-10-02 Euro Celtique Sa Analgesic composition
US4810501A (en) * 1986-06-17 1989-03-07 Warner-Lambert Company Sustained release pharmaceutical preparations
US4994276A (en) * 1988-09-19 1991-02-19 Edward Mendell Co., Inc. Directly compressible sustained release excipient
US4837030A (en) * 1987-10-06 1989-06-06 American Cyanamid Company Novel controlled release formulations of tetracycline compounds
US4851226A (en) * 1987-11-16 1989-07-25 Mcneil Consumer Products Company Chewable medicament tablet containing means for taste masking
US5135757A (en) * 1988-09-19 1992-08-04 Edward Mendell Co., Inc. Compressible sustained release solid dosage forms
US5169639A (en) * 1988-09-19 1992-12-08 Edward Mendell Co., Inc. Controlled release verapamil tablets
US5128143A (en) * 1988-09-19 1992-07-07 Edward Mendell Co., Inc. Sustained release excipient and tablet formulation
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
ATE133068T1 (de) * 1991-01-30 1996-02-15 Wellcome Found Wasserlösliche tabletten
GB9215908D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Water dispersible tablets
US5472711A (en) * 1992-07-30 1995-12-05 Edward Mendell Co., Inc. Agglomerated hydrophilic complexes with multi-phasic release characteristics
DE69332801T2 (de) * 1992-11-30 2004-01-29 Kv Pharm Co Geschmacksmaskierte pharmazeutische substanzen
IL119660A (en) * 1993-05-10 2002-09-12 Euro Celtique Sa Controlled release formulation comprising tramadol
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
US5891471A (en) * 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
KR100354702B1 (ko) * 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
US5843480A (en) * 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
GB9422154D0 (en) * 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
FR2760190B1 (fr) * 1997-02-28 1999-04-09 Adir Composition pharmaceutique pour la liberation programmee de dexfenfluramine
IN186245B (fr) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
US6375957B1 (en) 1997-12-22 2002-04-23 Euro-Celtique, S.A. Opioid agonist/opioid antagonist/acetaminophen combinations
PL193273B1 (pl) 1997-12-22 2007-01-31 Euro Celtique Sa Postać dawkowania doustnego
DE19918325A1 (de) 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
AUPQ573300A0 (en) 2000-02-21 2000-03-16 Australian Nuclear Science & Technology Organisation Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use
DE60238756D1 (de) 2001-05-11 2011-02-10 Endo Pharmaceuticals Inc Opioid enthaltende arzneiform gegen missbrauch
CA2478523A1 (fr) * 2002-04-05 2003-10-16 Euro-Celtique S.A. Matrice pour liberation prolongee, constante et independante de composes actifs
CA2531637A1 (fr) * 2003-07-23 2005-02-03 L. Perrigo Company Composition contenant des fibres cellulosiques
CA2560613C (fr) * 2004-03-22 2015-11-24 Solvay Pharmaceuticals Gmbh Compositions pharmaceutiques par voie orale a base de lipases, en particulier de pancreatine, contenant des tensioacitfs
EP1604667A1 (fr) * 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioides pour le traitement des impatiences des membres inférieurs
EP1604666A1 (fr) * 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioides pour le traitement de la bronchopneumopathie chronique obstructive
AU2006208627B8 (en) * 2005-01-28 2009-08-13 Mundipharma Pty Limited Alcohol resistant dosage forms
EP1702558A1 (fr) 2005-02-28 2006-09-20 Euro-Celtique S.A. Procédé et dispositif pour évaluer la fonction de l'activité intestinale
EP1695700A1 (fr) * 2005-02-28 2006-08-30 Euro-Celtique S.A. Forme posologique contenant de l'oxycodone et de la naloxone
WO2007014896A1 (fr) * 2005-07-29 2007-02-08 Solvay Pharmaceuticals Gmbh Procédé de fabrication de poudre de pancréatine stérilisée
US9198871B2 (en) * 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US11266607B2 (en) * 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
US10072256B2 (en) * 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
US20070286903A1 (en) * 2006-06-13 2007-12-13 Becicka Brian T Composition and method for taste masking
US20090130063A1 (en) * 2007-11-15 2009-05-21 Solvay Pharmaceuticals Gmbh Process for separating and determining the viral load in a pancreatin sample
SI2317991T1 (sl) * 2008-07-07 2017-09-29 Euro-Celtique S.A. Uporaba opioidnih antagonistov za zdravljenje retencije urina
ES2706407T3 (es) 2009-03-10 2019-03-28 Euro Celtique Sa Composiciones farmacéuticas de liberación inmediata que comprenden oxicodona y naloxona
AU2014295042B2 (en) 2013-07-23 2017-03-30 Mundipharma Pty Limited A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2993836A (en) * 1958-02-20 1961-07-25 Dow Chemical Co Sustained release tablets
US2980589A (en) * 1958-09-12 1961-04-18 American Cyanamid Co Process for producing anhydrous granulation of a medicinally active waterlabile powder
US3079303A (en) * 1958-12-11 1963-02-26 Smith Kline French Lab Basic tablet granulation and process of using same
FR1473805A (fr) * 1959-10-01 1967-03-24 Merck & Co Inc Véhicule pharmaceutique
US3133863A (en) * 1961-03-10 1964-05-19 Strong Cobb Arner Inc Sustained release therapeutic tablet compositions comprising organic solvent-gelled gums
US3148124A (en) * 1962-06-12 1964-09-08 William E Gaunt Method of preparing sustained release pharmaceutical tablets
US3453360A (en) * 1966-04-27 1969-07-01 Abbott Lab Universally useful stock material for manufacturing plastic dosage units by compression tableting processes
US3577514A (en) * 1968-06-10 1971-05-04 Pfizer Sustained release pharmaceutical tablets
US3507952A (en) * 1968-12-20 1970-04-21 Smithkline Corp Sustained release bolus for animal husbandry
GB1359643A (en) * 1970-09-28 1974-07-10 Controlled Medications Controlled release medicament
US3773920A (en) * 1971-07-14 1973-11-20 Nikken Chemicals Co Ltd Sustained release medicinal composition
US3773921A (en) * 1971-11-15 1973-11-20 Hoffmann La Roche Therapeutic compositions

Also Published As

Publication number Publication date
JPS5526124B2 (fr) 1980-07-11
HU168307B (fr) 1976-03-28
IN139518B (fr) 1976-06-26
NL158388B (nl) 1978-11-15
DK137706C (fr) 1982-11-15
FR2183546B1 (fr) 1975-06-20
BE799331A (fr) 1973-11-09
OA04380A (fr) 1980-02-15
JPS4992217A (fr) 1974-09-03
FI56623C (fi) 1980-03-10
IL42232A (en) 1976-08-31
FR2183546A1 (fr) 1973-12-21
AU5531473A (en) 1974-11-07
NL7306422A (fr) 1973-11-13
CA1041906A (fr) 1978-11-07
DE2323686A1 (de) 1973-11-22
GB1421964A (en) 1976-01-21
IL42232A0 (en) 1973-07-30
DD104027A5 (fr) 1974-02-20
FI56623B (fi) 1979-11-30
AR203268A1 (es) 1975-08-29
US3950508A (en) 1976-04-13
ZA733188B (en) 1975-01-29

Similar Documents

Publication Publication Date Title
DK137706B (da) Fremgangsmåde til fremstilling af tørre farmaceutiske produkter, som kan indgives oralt, og som har en virkning, der strækker sig over en vis tidsperiode.
DK128053B (da) Fremgangsmåde til fremstilling af farmaceutiske kapsler af hydroxyalkylalkylcelluloseethere.
NL170147C (nl) Werkwijze ter bereiding van een farmaceutisch preparaat, gevormd preparaat daarvan en heterocyclische diaminen hiervoor.
CH557173A (de) Kleinkind-lutscher.
DK137015B (da) Fremgangsmåde til fremstilling af et tværbundet, vanduopløseligt partikelformigt enzymprodukt.
DK138317B (da) Analogifremgangsmåde til fremstilling af cyklohexenonderivater.
SE7611467L (sv) Forfarande for framstellning av d-2,6-dimetyl-8-cyano(karboxamido)metylergolin
DK131707B (da) Fremgangsmåde til fremstilling af et kobbermyxinholdigt farmaceutisk præparat til behandling af otologiske og ophthalmologiske infektioner.
DK131864B (da) Fremgangsmåde til fremstilling af pregnan-21-syrederivater.
FI51765C (fi) Menetelmä säädetyn resorption omaavien kiinteiden lääketuotteiden valm istamiseksi.
DK128674B (da) Fremgangsmåde til fremstilling af tabletter indeholdende vandopløselige salte af α-carboxyester-substituerede phenylmethyl-penicilliner eller α-carboxyester-substituerede phenylmethyl-cephalosporiner til oral indgivning.
IS2050A7 (is) Efni afleidd úr acyli og aðferð til að framleiða þau.
DK136757B (da) Fremgangsmåde til fremstilling af acetylsalicylsyreholdige tyggetabletter.
SE398644B (sv) Sett att framstella farmaceutiskt aktiva 2,10-diklor-12-metyl-(2h-dibenso(d g))1,3)-dioxocinderivat
DK147695C (da) Fremgangsmaade til fremstilling af hoejt doserede tabletter af tetracyclin-derivater
DK131292B (da) Fremgangsmåde til fremstilling af et partikelformigt glucoseisomerase-holdigt præparat.
DK144872C (da) Fremgangsmaade til fremstilling af pyrazolonholdige tabletter
AR194812A1 (es) Procedimiento para la preparacion de diisoquinolildipiridil-butanos,y sales de ellos
DK136724B (da) Fremgangsmåde til fremstilling af 3-desacetoxycephalosporinderivater.
ES186112Y (es) Caramelo perfeccionado.
ES182103Y (es) Caramelo perfeccionado.
ES176856Y (es) Juego de habilidad, perfeccionado.
DK121802B (da) Fremgangsmåde til fremstilling af hypotensivt virksomme stoffer benævnt rugulovasin A og B, eller salte deraf.
ES183138Y (es) Un juego de habilidad, perfeccionado.
ES182057Y (es) Andamio perfeccionado.